Deepak Fertilis. Q1 FY27 Earnings Call — Analysis (NSE: DEEPAKFERT)
Deepak Fertilisers delivers historic best Q1 with record EBITDA ₹845 Cr (+65% YoY) and PAT ₹490 Cr (+101% YoY) driven by integrated value chain and elevated realizations; major capex projects near completion.
The take
Q1FY27 Revenue ₹3,256 Cr ( +22% YoY ) . New guidance — Q4FY27 utilization rate of new gopalpu… around 80% . New story: Integrated value chain resilience .
Results
Consolidated revenue ₹3,256 Cr +22% YoY; operating EBITDA ₹845 Cr +65% YoY; EBITDA margin 26% (vs 19% last year); net profit ₹490 Cr +101% YoY; net debt improved to 1.4x debt/EBITDA.
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue | ₹3,256 Cr | +22% | yoy · Q1FY27 · +8% QoQ |
| Operating EBITDA | ₹845 Cr | +65% | yoy · Q1FY27 · +139% QoQ |
| EBITDA Margin | 26% | +700 bps | yoy · Q1FY27 · vs 19% in Q1FY26, 12% in Q4FY26 |
| Net Profit | ₹490 Cr | +101% | yoy · Q1FY27 · +252% QoQ |
| Net Debt | ₹4,719 Cr | point_in_time · Q1FY27 · as of 30-Jun-2026 | |
| Debt/EBITDA | 1.4x | point_in_time · Q1FY27 · improved from 2.86x (likely FY26) | |
| Capex (quarter) | ₹500 Cr | point_in_time · Q1FY27 · incurred in Q1FY27 | |
| Cumulative Project Spend | ₹3,850 Cr | point_in_time · Q1FY27 · till Q1FY27, within approved capex envelope |
Guidance
Gopalpur TAN and Dahej nitric acid projects expected to commission in Q2 FY27, ramp-up targeted by Q4 FY27, with deleveraging to begin from FY27 as new capacities contribute.
What management committed to
- The [Gopalpur] TAN project and [Dahej] nitric acid project are expected to commence operations during Q2 FY27. — Q2FY27
- Both [Gopalpur TAN and Dahej nitric acid] projects remain within the approved capex envelope. — through project completion
- We should ramp up the [Gopalpur TAN and Dahej nitric acid] plants, aiming for around 80% utilization by Q4 FY27 if all goes well. — around 80%, Q4FY27
- Deleveraging of the balance sheet will start from FY27, with net debt/EBITDA ratio beginning to decline as new capacities contribute. — FY27
- The Equinor long-term LNG supply will fully replace the old existing gas contracts by Q4 FY27, making the company not dependent on any other gas source for ammonia. — FY27
Key themes
Integration benefits and peak capex completion driving record profitability
How the narrative shifted
- Integrated value chain resilience: Management emphasises the gas-to-ammonia-to-downstream integration, including the new Equinor LNG contract, as a structural moat delivering cost visibility and margin stability.
- Geopolitical tailwind: Middle East conflict and supply disruptions elevate ammonia and TAN prices, benefiting near-term realizations, but management tempers expectations with a 'new normal' post-war.
- Capex completion and growth leap: Both major projects at 93-96% completion, commissioning imminent, set to drive top-line and bottom-line expansion; management promises faster ramp-up due to similar chemistry.
- Shift to specialty and B2C premiumization: B2C in mining chemicals and specialty/customised products in crop nutrition and industrial chemicals are expanding, improving margins and stickiness; explosives TCO model reinforces this.
- Deleveraging and balance sheet discipline: Peak debt levels reached; strong cash generation and new project EBITDA to drive deleveraging starting FY27.
- Monsoon-driven crop nutrition recovery: El Niño over, good rains to boost fertilizer demand, but subsidy corrections and raw material cost pressures remain watch items.
Operational commentary
- Integrated value chain strengthened: 15-year LNG contract with Equinor commenced, first cargo received in May; ammonia plant debottlenecked with ~10% capacity improvement, Q1 utilization at 94%.
- TAN Gopalpur project 96% complete, Dahej nitric acid project 93% complete; both on track for commissioning in Q2 FY27 within approved capex.
- Mining chemicals B2C revenue grew 42% YoY to ₹151 Cr, now 17% of segment revenue, advancing premiumization and customer stickiness.
- Industrial chemicals: nitric acid volumes stable, IPA volumes disrupted by propylene availability but pharma-grade demand strong; recovery expected as propylene improves.
- Crop nutrition: specialty & Croptek products now 43% of segment revenue; business resilient despite delayed monsoon and subsidy gaps.
- Acquisition of an explosives company in May 2026 to complete mining solutions value chain; upgrade and expansion to TCO model underway.
- Temporary PESO portal disruption caused TAN volume loss of few days; resolved and behind the company.
- Balance sheet: net debt reduced to ₹4,719 Cr, debt/EBITDA improved to 1.4x despite >₹500 Cr capex in the quarter; peak debt levels near.
Analyst Q&A
Q. Can we expect similar EBITDA margins as Q1 for the full year?
I won't say that. It's too difficult, too early for any of us to make that estimate.
Q. How do you see the explosive business opportunity and entry of a major refiner into TAN?
Explosives acquisition: upgrading facility, will roll out TCO model; on new entrant: no details, too early to comment.
Q. What is the PAT expectation for full year FY27 and contribution from new capex?
Will not give specific numbers; but base level will change to an elevated level by year-end as new capacities and gas benefits flow.
Research and educational content only. Not investment advice.